AU6264700A - Ciprofloxacin hydrates and method for their production - Google Patents

Ciprofloxacin hydrates and method for their production

Info

Publication number
AU6264700A
AU6264700A AU62647/00A AU6264700A AU6264700A AU 6264700 A AU6264700 A AU 6264700A AU 62647/00 A AU62647/00 A AU 62647/00A AU 6264700 A AU6264700 A AU 6264700A AU 6264700 A AU6264700 A AU 6264700A
Authority
AU
Australia
Prior art keywords
ciprofloxacin
hydrates
production
ciprofloxacin hydrates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU62647/00A
Other languages
English (en)
Inventor
Michael Preiss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU6264700A publication Critical patent/AU6264700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU62647/00A 1999-07-02 2000-06-21 Ciprofloxacin hydrates and method for their production Abandoned AU6264700A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19930557 1999-07-02
DE19930557A DE19930557B4 (de) 1999-07-02 1999-07-02 Verfahren zur Herstellung von Hydraten von Ciprofloxacin und von Ciprofloxacin-Anhydrat enthaltenden pharmazeutischen Zusammensetzungen
PCT/EP2000/005743 WO2001002365A1 (de) 1999-07-02 2000-06-21 Hydrate von ciprofloxacin und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
AU6264700A true AU6264700A (en) 2001-01-22

Family

ID=7913431

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62647/00A Abandoned AU6264700A (en) 1999-07-02 2000-06-21 Ciprofloxacin hydrates and method for their production

Country Status (3)

Country Link
AU (1) AU6264700A (de)
DE (1) DE19930557B4 (de)
WO (1) WO2001002365A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003010144A2 (en) * 2001-07-25 2003-02-06 Farmaceutsko-Hemijska Industrija 'zdravlje' A process for synthesis of fluoroquinolonic derivatives
DE102005053679A1 (de) * 2005-06-24 2006-12-28 Bayer Healthcare Ag Therapeutischer Einsatz von Moxifloxacin zur Rekonstruktion von Funktionsstörungen des Immunsystems

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670444B1 (en) * 1980-09-03 1999-02-09 Bayer Ag and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds
US4620007A (en) * 1980-09-03 1986-10-28 Bayer Aktiengesellschaft 6-fluoro-7-chloro-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid
ES2006099A6 (es) * 1988-03-03 1989-04-01 Investchemi S A Procedimiento para la obtencion de hidrocloruro de ciprofloxacina monohidrato.
ES2006098A6 (es) * 1988-03-03 1989-04-01 Investchemi S A Procedimiento de obtencion de hidrocloruro de ciprofloxacina monohidrato.
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel

Also Published As

Publication number Publication date
DE19930557A1 (de) 2001-01-04
WO2001002365A1 (de) 2001-01-11
DE19930557B4 (de) 2005-12-08

Similar Documents

Publication Publication Date Title
AU2003277270B2 (en) Inorganic shaped bodies and methods for their production and use
AU2001279683A1 (en) Biosensor and method for production thereof
AU1854901A (en) Novel method
AU2002250858A1 (en) Capsule-in-capsule system and method for the production thereof
AU7819200A (en) Method and device for production of beverages
AU2351001A (en) Stent and method for the production thereof
AU2001267888A1 (en) Production planning method and system for production planning
AU7292300A (en) Synchronization method and synchronization arrangement
AU2964500A (en) Method of micro-fabrication
AU1105301A (en) Micro-multiport tubing and method for making same
AU7445100A (en) Sebum production inhibitors
AU5057600A (en) Component and method for the production thereof
AU2757600A (en) Yo-yo and method for manufacture
AU2001264134A1 (en) Microconnectors and method for their production
AU6466100A (en) Method and device for continuous production of ice-solution suspension
AU2744900A (en) Method and apparatus for manufacturing design
AU2002212874A1 (en) High strength ceramised glass and method for production thereof
AU2570001A (en) Pharmaceutical composition and method for its manufacture
AU4751300A (en) Method and device for the continuous production of NaAlCl4 or NaFeCl4
AU6264700A (en) Ciprofloxacin hydrates and method for their production
AU3843900A (en) Microbiological production method for alpha-l-aspartyl-l-phenylalanine
AU2001274004A1 (en) Method for the production of 2- coumarone and substituted 2-coumarones
AU5174699A (en) Apparatus and method for the production of disinfectant
AU6835500A (en) Tissue substitute and method for the production thereof
AU7516300A (en) Double filter cigarette and method for production thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase